ENTA logo

ENTA P/OCF Ratio

Current (TTM)-9.32×
ENTA Quarterly P/OCF Ratio (-60.48× → -42.53×)
High-resolution chart · PNG

ENTA p/ocf ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Enanta Pharmaceuticals Inc P/OCF Ratio — Quarterly
Period endingP/OCF Ratio
-42.5323×
-51.2542×
-38.7517×
-39.4388×
9.2079×
-8.7396×
-7.2685×
-21.1085×
-18.7359×
-12.5961×
-7.9413×
-10.8882×
-14.0238×
-61.7177×
-27.1698×
-68.796×
-33.0708×
-55.4624×
-114.8832×
-54.5309×
-30.112×
-217.26×
-56.811×
-59.4391×
-223.976×
69.8234×
98.6991×
138.4125×
668.1675×
61.5463×
45.4797×
57.5157×
552.6724×
-205.0617×
254.6039×
15.5959×
-143.1473×
-195.4189×
202.7895×
-238.2634×
-198.189×
53.3935×
20.6709×
-284.768×
-59.2257×
5.7857×
-168.6208×
-149.1417×
22.7283×
-177.7147×
-83.1736×
-96.5582×
-18.1382×
8.7895×
17.7785×
-94.4807×
-42.0079×
5.1309×
-69.0591×
-60.4836×
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.